# Qualitative analysis — gemma-3-4b-it / test_id

Case identifiers are configured in `src/eval/qualitative.py` (`CASE_IDS`).

| Case | id | `gemma-3-4b-it` | `gemma-3-4b-it-qlora-finetune` | `medgemma-4b-it` |
|---|---|---|---|---|
| 1 | `de09d388-bd4e-42a9-ac6b-ee2d95f822e2` | `B` ✓ | `B` ✓ | `B` ✓ |
| 2 | `d2398cd6-b205-4fb3-a4c4-9e575662b0bf` | `A` ✓ | `—` ✗ | `A` ✓ |

---

## Case 1

- **id**: `de09d388-bd4e-42a9-ac6b-ee2d95f822e2`
- **gold**: `B`
- **predicted**: `B` (parse_success=True)

**Model generation:**

```text
Okay, let’s break down this clinical scenario and arrive at the most probable diagnosis.

**Step 1: Understanding the Symptoms**

*   **Blue newborn:** Cyanosis indicates inadequate oxygenation of the blood, leading to bluish discoloration of the skin. This points towards a problem with gas exchange - getting enough oxygen into the bloodstream.
*   **Oligemic lung fields:** Oligaemia means reduced pulmonary perfusion (blood flow).  This suggests that not enough blood is reaching the lungs to facilitate oxygen uptake.
*   **Normal-sized heart:** This is crucial information. It rules out some conditions where the heart itself might be abnormally large due to increased workload.

**Step 2: Evaluating Each Option**

*   **(A) Ebstein's Anomaly:** This involves an abnormal attachment of the tricuspid valve leaflets to the right ventricular outflow tract. While it can cause cyanosis, it typically doesn't present with *oligaemic lung fields*. Ebstein's primarily affects cardiac output and valve function, not necessarily pulmonary vascular resistance or perfusion directly.

*   **(B) Pulmonary Atresia:** This condition involves absent or underdeveloped pulmonary valve and/or pulmonary artery. Without a functional pulmonary valve, blood cannot effectively flow from the left side of the heart to the lungs for oxygenation. This would lead to severe oligemia in the lungs and significant cyanosis. The normal heart size is also consistent with this presentation.

*   **(C) Transposition of Great Arteries (TGA):** In TGA, the aorta arises from the right ventricle and the pulmonary artery arises from the left ventricle. There's no mixing of deoxygenated and oxygenated blood between the two sides of the heart. This results in cyanotic circulation. However, while there will be cyanosis, the lung fields may appear relatively clear initially because the lack of systemic pressure does not immediately affect pulmonary vasculature. Furthermore, the heart size could vary depending on compensatory mechanisms.

*   **(D) Tetralogy of Fallot:** This complex congenital heart defect includes four abnormalities: pulmonary stenosis, overriding aorta, ventricular septal defect, and right ventricular hypertrophy. It causes desaturated blood to shunt through the aorta, resulting in cyanosis. However, the classic presentation often shows signs of increased pulmonary vascular resistance, which wouldn't manifest as ‘oligaemic lung fields’.


**Step 3: Comparing Options & Determining the Best Fit**

Considering all the symptoms—cyanosis and oligemic lung fields—Pulmonary Atresia stands out as the most likely diagnosis. The absence of a pulmonary valve leads to severely restricted blood flow to the lungs, causing both cyanosis and decreased pulmonary perfusion.

**Final Answer:**

Answer: B
```

## Case 2

- **id**: `d2398cd6-b205-4fb3-a4c4-9e575662b0bf`
- **gold**: `A`
- **predicted**: `A` (parse_success=True)

**Model generation:**

```text
Okay, let's break down this question about iron metabolism and how each of these factors plays a role.

**Understanding Iron Metabolism:** Iron metabolism is a tightly regulated process involving absorption, storage, transport, and utilization within the body. It’s crucial for oxygen carrying (hemoglobin), enzyme function, and various other cellular processes. Let's examine each option:

*   **A) Transthyretin:** This protein transports thyroid hormones (T3 and T4). Importantly, it *also* has a minor but measurable role in transporting some free iron in plasma. While its primary function isn't iron metabolism, it does contribute to iron distribution.

*   **B) Ceruloplasmin:**  Ceruloplasmin is absolutely critical for iron homeostasis. It’s the major carrier protein for copper *and* it also plays a vital role in solubilizing ferric iron (Fe<sup>3+</sup>), making it available for uptake into cells. Without ceruloplasmin, iron becomes largely insoluble and unavailable for use.

*   **C) Hepcidin:** Hepcidin is arguably *the* master regulator of iron metabolism. Produced primarily by the liver, it controls intestinal iron absorption, macrophage iron release, and systemic iron availability. It effectively blocks ferroportin, the key protein responsible for exporting iron from enterocytes to circulation and macrophages.

*   **D) Ferroportin:** Ferroportin is the only known mammalian cell surface transporter of nonheme iron. It’s found on enterocytes (intestinal cells), macrophages, and hepatocytes (liver cells). It ferries iron out of these cells into the bloodstream. Hepcidin directly binds to and inhibits ferroportin, thus controlling iron outflow.


Based on this analysis, we can see that transthyretin’s involvement in iron metabolism is minimal compared to the others. The other three – ceruloplasmin, hepcidin, and ferroportin - are all central players in regulating iron levels throughout the body.

Answer: A
```
